A Phase II/III Study of NPC-09 (N-acetylneuraminic acid) in Patients with GNE Myopathy (GNEM)
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Aceneuramic acid (Primary)
- Indications Nonaka distal myopathy
- Focus Therapeutic Use
- Sponsors Nobelpharma
- 24 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Aug 2016 Planned End Date changed from 31 Mar 2017 to 30 Sep 2017.
- 20 May 2016 New trial record